Literature DB >> 16933061

Obesity and the risk of Hodgkin lymphoma (United Kingdom).

Eleanor V Willett1, Eve Roman.   

Abstract

OBJECTIVE: The aim of the study was to investigate the relationship between Hodgkin lymphoma (HL) and obesity.
METHODS: A population-based case-control study recruited incident cases of lymphoma in England during 1998-2003. Information on height and weight was collected from 216 cases with a histologically confirmed incident diagnosis of HL and their age- and sex-matched controls.
RESULTS: Obesity, defined as a body mass index of 30 kg m(-2) or above at 5 years prior to diagnosis, increased the risk of HL more than 2-fold compared to those in the normal range of 18.5-<25 kg m(-2) (odds ratio (OR) = 2.2, 95% confidence interval (CI): 1.1, 4.3). The association was more prominent among men (OR = 2.8, 95% CI: 1.2, 6.5) than women (OR = 1.1, 95% CI: 0.3, 3.8). Elevated risks tended to be among older (aged 36-50 and 51-69) rather than younger persons (aged < or =35 years), and for EBV-ve, rather than EBV+ve, HL.
CONCLUSIONS: This study suggests that obesity may increase the risk of HL, particularly among men. Further investigations are needed to confirm these findings.

Entities:  

Mesh:

Year:  2006        PMID: 16933061     DOI: 10.1007/s10552-006-0042-6

Source DB:  PubMed          Journal:  Cancer Causes Control        ISSN: 0957-5243            Impact factor:   2.506


  7 in total

1.  The Impact of Obesity on Hodgkin's Lymphoma Patients Treated With Uniform Chemotherapy Protocol at Princess Noorah Oncology Center, National Guard Health Affairs, Jeddah, Saudi Arabia: Retrospective Matched Cohort.

Authors:  Alaa T Alsharif; Mohammed Aldawsari; Emad M Babateen; Meshaal A Kouther; Faisal F Aljahdali; Ahmed Absi; Taghreed Aldosary; Mohamed E Ahmed
Journal:  Cureus       Date:  2022-05-14

2.  Body size and risk of Hodgkin's lymphoma by age and gender: a population-based case-control study in Connecticut and Massachusetts.

Authors:  Qian Li; Ellen T Chang; Bryan A Bassig; Min Dai; Qin Qin; Yongshun Gao; Yawei Zhang; Tongzhang Zheng
Journal:  Cancer Causes Control       Date:  2012-12-04       Impact factor: 2.506

Review 3.  Obesity and the risk for a hematological malignancy: leukemia, lymphoma, or myeloma.

Authors:  Marshall A Lichtman
Journal:  Oncologist       Date:  2010-10-07

4.  Body composition measurements and risk of hematological malignancies: A population-based cohort study during 20 years of follow-up.

Authors:  Hannes Hagström; Anna Andreasson; Axel C Carlsson; Mats Jerkeman; Mattias Carlsten
Journal:  PLoS One       Date:  2018-08-23       Impact factor: 3.240

5.  Risk factors for Epstein Barr virus-associated cancers: a systematic review, critical appraisal, and mapping of the epidemiological evidence.

Authors:  Deniz Bakkalci; Yumeng Jia; Joanne R Winter; Joanna Ea Lewis; Graham S Taylor; Helen R Stagg
Journal:  J Glob Health       Date:  2020-06       Impact factor: 4.413

6.  Hodgkin's lymphoma and infection: findings from a UK case-control study.

Authors:  R Newton; S Crouch; P Ansell; J Simpson; E V Willett; A Smith; C Burton; A Jack; E Roman
Journal:  Br J Cancer       Date:  2007-09-25       Impact factor: 7.640

7.  Genome-wide association study of classical Hodgkin lymphoma identifies key regulators of disease susceptibility.

Authors:  Amit Sud; Hauke Thomsen; Philip J Law; Asta Försti; Miguel Inacio da Silva Filho; Amy Holroyd; Peter Broderick; Giulia Orlando; Oleg Lenive; Lauren Wright; Rosie Cooke; Douglas Easton; Paul Pharoah; Alison Dunning; Julian Peto; Federico Canzian; Rosalind Eeles; ZSofia Kote-Jarai; Kenneth Muir; Nora Pashayan; Per Hoffmann; Markus M Nöthen; Karl-Heinz Jöckel; Elke Pogge von Strandmann; Tracy Lightfoot; Eleanor Kane; Eve Roman; Annette Lake; Dorothy Montgomery; Ruth F Jarrett; Anthony J Swerdlow; Andreas Engert; Nick Orr; Kari Hemminki; Richard S Houlston
Journal:  Nat Commun       Date:  2017-12-01       Impact factor: 14.919

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.